Stock futures edged slightly higher on Monday night as investors processed a wave of fresh earnings reports and Wall Street recovered from last week’s sell-off.
By 9:15 am AEST (11:15 pm GMT), futures tied to the Dow Jones Industrial Average, S&P 500, and Nasdaq 100 were each up 0.1%.
In after-hours trading, Palantir Technologies rose 4.6% after beating Wall Street estimates for the second quarter. The defence and AI software company reported adjusted earnings per share (EPS) of $0.16 on $1 billion in revenue, exceeding consensus forecasts of $0.14 and $937.7 million, respectively.
Vertex Pharmaceuticals, however, slid 14.3% despite beating second-quarter expectations. The biotech firm posted adjusted EPS of $4.52 on revenue of $2.94 billion, beating estimates of $4.27 and $2.91 billion.
Hims & Hers Health tumbled 13.4% after the telehealth company issued a disappointing third-quarter outlook. The company forecast adjusted EBITDA between $60 million and $70 million, missing the $77 million expected, while second-quarter revenue came in below expectations, and adjusted earnings narrowly beat.
The modest gains follow a sharp rebound during Monday’s regular session, where the S&P 500 surged 1.5% to snap a four-day losing streak. The Dow climbed 1.3%, erasing Friday’s losses, while the Nasdaq Composite jumped nearly 2%.
The latest moves come as investor attention remains fixed on the state of the U.S. economy. Friday’s market rout, sparked by a weaker-than-expected jobs report and the rollout of new tariffs under President Donald Trump, raised fresh concerns over growth and policy risks.
Traders are now turning to another busy day of earnings on Tuesday, with Pfizer, Yum! Brands, and Fox Corporation reporting before the market opens.
After the bell, Snap, Advanced Micro Devices, and Rivian will release their quarterly results.
